BlackRock Institutional Trust’s SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) SKBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-175,708
Closed -$167K 4013
2015
Q3
$167K Sell
175,708
-100
-0.1% -$160 ﹤0.01% 3663
2015
Q2
$468K Hold
175,808
﹤0.01% 3519
2015
Q1
$687K Hold
175,808
﹤0.01% 3440
2014
Q4
$742K Hold
175,808
﹤0.01% 3418
2014
Q3
$737K Buy
175,808
+7,622
+5% +$41.4K ﹤0.01% 3410
2014
Q2
$1.23M Buy
168,186
+26,568
+19% +$158K ﹤0.01% 3375
2014
Q1
$929K Buy
141,618
+46,365
+49% +$235K ﹤0.01% 3437
2013
Q4
$334K Buy
+95,253
New +$420K ﹤0.01% 3640

Other funds holding SKBI

BlackRock Institutional Trust's SKBI Position: Q4 2015 in Review

BlackRock Institutional Trust sold out of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) in Q4 2015, closing a stake of 175,708 shares — an estimated $167K sold.

BlackRock Institutional Trust first reported a position in SKBI in Q4 2013 and held it in 8 quarters. The position peaked at $1.23M in Q2 2014. 1 fund tracked by Wall St. Rank holds SKBI as of Q4 2015.

  • BlackRock Institutional Trust reported no remaining SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position as of Q4 2015 after selling out during the quarter.
  • BlackRock Institutional Trust sold 175,708 SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) shares in Q4 2015, an estimated $167K.
  • BlackRock Institutional Trust first reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in Q4 2013 and held it in 8 quarters.
  • BlackRock Institutional Trust's SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position peaked at $1.23M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) as of Q4 2015.

Based on BlackRock Institutional Trust's 13F filing for Q4 2015, filed 11 Feb 2016.